In response, leading pharmas have announced massive capacity expansions: Novo Nordisk plans a $4.1 billion manufacturing facility in North Carolina ( [5] ) (opening ~2029), and Lilly has committed over $15 billion for new plants in Indiana, Wisconsin, Pennsylvania, and Alabama ( [6] ) ( [7] ) ( [8] ) ( [9] )
Tsigalou C, Konstantinidis T, Paraschaki A, Stavropoulou E, Voidarou C, Bezirtzoglou E
Treatment of NAFLD with diet, physical activity and exercise
The peptide is most commonly administered once daily in the morning on an empty stomach, though some protocols use twice-daily dosing
While Mounjaro might be covered when prescribed for type 2 diabetes and Zepbound for OSA, most people who get the medication for weight loss (off-label or not) wont get insurance coverage
They may adjust the dosage of the medication